Core One Labs Inc. announced it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products. Dr. Ferro is a world-renowned physician with over 20 years’ experience in pharmaceuticals, biologicals and biotech industries. Dr. Ferro’s impressive resume includes appointments as Chief of Internal Medicine at Central Military Hospital in Bogotá, President of the Colombian Infectious Disease Society, Clinical Team Leader for new vaccines at Sanofi Pasteur in Toronto, Infectious Disease Expert at Novartis Pharmaceuticals in New Jersey - where, he was also member of the internal Scientific Review Board and deeply involved in drug development - and Medical Director at PATH’s Malaria Vaccine Initiative in Bethesda, Maryland where he led a team of clinical researchers, which jointly worked with Glaxo Smith Klein’s team to implement a large phase 3 clinical trial for a malaria vaccine candidate in 7 Sub-Saharan African countries.